Tip - MBX Biosciences may be worth a look?

MBR has gone up over 100% recently and there has also been some insider buying. It has a target price of approx $60 and so seems undervalued.

The company has a few drugs in the pipeline including a GLP-1 weight loss drug which should only require an injection once a month instead of once a week. This is in Phase 1 trials at the moment, so it won't be produced until at least 2027 but the share price may rocket if Phase 1 goes well and it will go even higher after Phase II testing.

As always, investing in pharmaceutical companies is risky - the trials could fail or a better/cheaper drug may be produced by a competitor. My intention is to sell as soon as it shows a nice profit, but others may prefer to hold on for the ride!

Note: this is not investing advice - this type of company is a risky investment, so do not invest more than you can afford to lose!

P.S. 

My investment in Regeneron Pharmaceuticals (tipped 15th Nov 2025) is doing OK so far too...

Use this link to join Trading 212 and get up to £100 free shares!